Breast Cancer Tumor Care Patient Observation Programme.
Latest Information Update: 13 Jun 2012
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors AstraZeneca
- 05 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2009 Planned end date changed from Sep 2009 to Dec 2009 as reported by ClinicalTrials.gov.
- 11 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.